These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7187559)

  • 1. [Polyvinylpyrrolidone as a stimulator of the immunogenic activity of inactivated influenza vaccine].
    Bichurina MA; Rozaeva NR; Ishkil'din MI; Degtiarev AA
    Tr Inst Im Pastera; 1982; 59():109-12. PubMed ID: 7187559
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunogenic and reactogenic properties of commercial series of inactivated chromatographic influenza vaccine].
    Peĭsel' SG; Nifontova AI; Zhebrun AB; Karpovich NM; Slatin EA
    Tr Inst Im Pastera; 1979; 52():38-42. PubMed ID: 550545
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reactogenicity and safety of inactivated chromatographic influenza vaccine in a contingent of immune donors being revaccinated].
    Tentser PS; Bundzen NG
    Tr Inst Im Pastera; 1979; 52():43-50. PubMed ID: 550546
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunostimulating action of certain compounds in an experiment on laboratory animals].
    Nikitina LE; Maslennikova LK; Noskov FS
    Tr Inst Im Pastera; 1982; 59():112-6. PubMed ID: 7187560
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prophylactic effectiveness of an inactivated formol influenza vaccine].
    Agafonov VI; Perepelkin VS; Chemeris EA; Novikov NL
    Voen Med Zh; 1981 Feb; (2):36-8. PubMed ID: 7233843
    [No Abstract]   [Full Text] [Related]  

  • 6. [Increase in the specific activity of killed influenza vaccines by using polyene antibiotics].
    Shneĭder MA; Shtil'bans EB; Paleĭ EI; Vil'ner LM; Tereshin IM
    Antibiotiki; 1981 Jul; 26(7):532-7. PubMed ID: 7271267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Obtaining a lyophilized preparation of inactivated influenza vaccine].
    Goriunova VV; Bichurina MA; Gerasimov VA
    Tr Inst Im Pastera; 1979; 52():110-4. PubMed ID: 550533
    [No Abstract]   [Full Text] [Related]  

  • 8. [Safety of viral vaccines (a review)].
    Peradze TV; Fridman EA
    Tr Inst Im Pastera; 1979; 52():9-18. PubMed ID: 550552
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of the passive local hemolysis method for studying the immunostimulating activity of compounds].
    Maslennikova LK
    Tr Inst Im Pastera; 1982; 59():106-9. PubMed ID: 6764985
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant activity of polar glycopeptidolipids of Mycobacterium chelonae (pGPL-Mc) on the immunogenic and protective effects of an inactivated influenza vaccine.
    Gjata B; Hannoun C; Boulouis HJ; Neway T; Pilet C
    C R Acad Sci III; 1994 Mar; 317(3):257-63. PubMed ID: 7994612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation of an influenza vaccine from allantoic viral cultures inactivated with UV irradiation].
    Polianskaia NIu
    Tr Inst Im Pastera; 1979; 52():107-10. PubMed ID: 550532
    [No Abstract]   [Full Text] [Related]  

  • 12. [Possibility of preparing inactivated influenza vaccine by a combination of gel chromatography and ultrafiltration].
    Fridman AL; Ermolaev AI; Bichurina MA; Polianskaia NIu; Zheleznova NV
    Tr Inst Im Pastera; 1979; 52():103-7. PubMed ID: 550531
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally.
    Ghendon Y; Markushin S; Vasiliev Y; Akopova I; Koptiaeva I; Krivtsov G; Borisova O; Ahmatova N; Kurbatova E; Mazurina S; Gervazieva V
    J Med Virol; 2009 Mar; 81(3):494-506. PubMed ID: 19152418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A one-size-fits-all flu vaccine?
    Kaiser J
    Science; 2006 Apr; 312(5772):380-2. PubMed ID: 16627732
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel synthetic adjuvant effectively enhances the immunogenicity of the influenza vaccine.
    Segura-Velázquez R; Pérez-Torres A; Rosas G; Toledo A; Restelli M; Acosta E; Corral R; Rosetti F; Fragoso G; Grinstein S; Sciutto E
    Vaccine; 2006 Feb; 24(8):1073-80. PubMed ID: 16202486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Delayed-type hypersensitivity reaction induced in mice by the administration of an inactivated influenza vaccine].
    Shpiliuk F; Shapiro NI; Polianskia NIu; Guskin IaR; Suhinin VP
    Virologie; 1987; 38(2):127-33. PubMed ID: 3617497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity.
    de Vries JJ; Bungener L; Ter Veer W; van Alphen L; van der Ley P; Wilschut J; Huckriede A
    Vaccine; 2009 Feb; 27(6):947-55. PubMed ID: 19059296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice.
    Quintilio W; Kubrusly FS; Iourtov D; Miyaki C; Sakauchi MA; Lúcio F; Dias Sde C; Takata CS; Miyaji EN; Higashi HG; Leite LC; Raw I
    Vaccine; 2009 Jun; 27(31):4219-24. PubMed ID: 19393709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of inactivated vaccines against influenza].
    Peradze TV; Fridman EA
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Sep; (9):28-34. PubMed ID: 6755982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.